Drug
Who makes scopolamine transdermal system?
2 companies list scopolamine transdermal system as a human prescription drug. Forms: patch, extended release. Routes: transdermal.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing scopolamine transdermal system
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Padagis Israel Pharmaceuticals LtdUnited States | patch, extended release | ANDAANDA078830 | 1 | 2 |
| Bryant Ranch PrepackUnited States | patch, extended release | ANDAANDA078830 | 1 | 1 |
Enquiry
Common questions
- Who makes scopolamine transdermal system?
- 2 companies list scopolamine transdermal system as a human prescription drug in the openFDA NDC Directory, led by Padagis Israel Pharmaceuticals Ltd, Bryant Ranch Prepack. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic scopolamine transdermal system?
- 2 companies list scopolamine transdermal system under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.